Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$259.6 million.

  • Maravai Lifesciences Holdings' Net Income towards Common Stockholders rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Net Income towards Common Stockholders is -$259.6 million, which was down 87.62% from -$138.4 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Net Income towards Common Stockholders peaked at $490.7 million during FY2022, and registered a low of -$259.6 million during FY2024.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$138.4 million (2023), whereas its average is $30.9 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Net Income towards Common Stockholders surged by 1,615.40% in 2020 and then slumped by 128.20% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Net Income towards Common Stockholders (Yearly) stood at $78.8 million in 2020, then skyrocketed by 495.37% to $469.2 million in 2021, then climbed by 4.56% to $490.7 million in 2022, then crashed by 128.20% to -$138.4 million in 2023, then tumbled by 87.62% to -$259.6 million in 2024.